This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Investigating the Direct Superior Approach for Total Hip Arthroplasty as an Effective Alternative to Traditional Posterior Approach

Sponsored by Nova Scotia Health Authority

About this trial

Last updated 2 years ago

Study ID

THA DSA

Status

Active not recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18 to 81 Years
All Sexes

Trial Timing

Ended 6 months ago

What is this trial about?

Hip replacement surgery is an effective option for treating pain and functional impairment in chronic hip conditions. Various surgical approaches have been developed to expose the hip joint for the procedure, each with advantages and disadvantages. The posterior approach (PA) to total hip replacement is a commonly used exposure method. This approach involves a large incision and requires multiple cuts through muscle and other soft tissues to expose the hip joint. Despite excellent outcomes, the PA is known to have an increased rate of dislocation compared to other exposures. The direct superior (DS) approach has been developed to improve the PA by decreasing the amount of soft tissue injury at the time of surgery and improving postoperative stability. The DS approach involves a much shorter incision and reduces the need to damage as much soft tissues surrounding the hip joint during exposure. Specialized equipment developed for this technique allows the surgeon to place the hip replacement components. The proposed research study is designed to address a deficit in knowledge regarding outcomes on patients who have had a DS approach for total hip arthroplasty. This study will provide much needed insight into the advantages and disadvantages of the DS approach as compared to PA for total hip arthroplasty.

What are the participation requirements?

Inclusion Criteria

* Symptomatic osteoarthritis of the hip indicating surgical intervention

* Uncemented femoral stem and acetabular cup indicated

* Patients between the ages of 18 and 80, inclusive.

* Ability to give informed consent

Exclusion Criteria

* Patients less than 18 years of age, or 81 years of age and older

* Active or prior infection of the affected hip

* Morbid obesity (BMI > 45)

* Medical condition precluding major surgery

* Severe osteoporosis or osteopenia

* Neuromuscular impairment

* Patients with known or tested-positive allergy to metals

* Pregnancy